Cartesian Therapeutics, Inc. Preferred Stock Dividends and Other Adjustments
Cartesian Therapeutics, Inc. (RNAC) reported Preferred Stock Dividends and Other Adjustments of $0 for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2023-11-13
- Cartesian Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2023-09-30 was $0.00.
- Cartesian Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2023-06-30 was $0.00.
- Cartesian Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Cartesian Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2022-09-30 was $0.00.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month |
|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-17 | $0.00 10-Q · filed 2023-08-17 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $7.33M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-17 | $13.87M 10-Q · filed 2023-08-17 | |
| 2022-03-31 | $18.52M 10-Q · filed 2023-05-04 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $4.82M derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 |
| 2021-06-30 | $4.82M 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |